Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Heading Into Fourth Pelvic Mesh Bellwether

Executive Summary

The Philadelphia trial is getting underway just days after a jury handed down a $20m verdict against the company in the third bellwether case.

You may also be interested in...



Court Rules Against Ethicon In Pelvic Mesh Case, But Without Punitive Damages

A jury awarded $2.16 million in the case, making it the first time a jury in a pelvic mesh case has ruled in a plaintiff’s favor without including punitive damages. Meanwhile, Ethicon is also appealing an earlier case to the US Supreme Court, and CR Bard has settled almost 100 pelvic mesh cases pending in West Virginia.

Judge Upholds $14M Pelvic Mesh Award

A Pennsylvania jury’s verdict awarding $13.7m to a woman who says she was injured by Ethicon’s Gynecare TVT mesh has been backed by a judge. The case will likely be appealed to the state’s Superior Court.

Warning Letter Close-Outs – November 2020

The US Food and Drug Administration posted two device-related closeout letters in November.

Topics

Related Companies

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel